🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Amy E. Moran

Oregon Health & Science University

ORCID: 0000-0003-1952-7737
MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 5%percentile
0.418Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Deciphering single-cell heterogeneity and cellular ecosystem dynamics during prostate cancer progression

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.12.18.629070
Top 44%
0.418DataRank
Top 44%10 citations

Jianming Zeng, Canping Chen, Xiaofan Zhao, Tingting Zhang, George Thomas +7 more

Papers

Driven by 15 papers — median percentile 56. Top paper: “Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy”.

Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy

Nature(2022)10.1038/s41586-022-04833-8
N/A
0.731DataRank · unranked
130 citations

Michael G. White, Miles C. Andrews, Manoj Chelvanambi, Russell G. Witt, Joseph R. Daniele +60 more

Androgen Receptor Inhibition Increases MHC Class I Expression and Improves Immune Response in Prostate Cancer

Cancer Discovery(2024)10.1158/2159-8290.cd-24-0559
N/A
0.590DataRank · unranked
50 citations

Fanny Polesso, Julie N. Graff, Jessica E. Hawley, Alexis K. Smith, Arian Lundberg +35 more

Deciphering single-cell heterogeneity and cellular ecosystem dynamics during prostate cancer progression

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.12.18.629070
Top 44%
0.418DataRank
Top 44%10 citations

Jianming Zeng, Canping Chen, Xiaofan Zhao, Tingting Zhang, George Thomas +7 more

Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.9523
N/A
0.259DataRank · unranked
4 citations

Christopher P. Vellano, Miles C. Andrews, Russell G. Witt, Manoj Chelvanambi, Jennifer L. McQuade +15 more

Supporting the Next Generation of Scientists to Lead Cancer Immunology Research

Cancer Immunology Research(2021)10.1158/2326-6066.cir-21-0519
N/A
0.121DataRank · unranked
1 citations

Ryan D. Chow, Shadmehr Demehri, Jennifer L. Guerriero, Shashi Gujar, Felix J. Hartmann +24 more

Phenotype-guided subpopulation identification from single-cell sequencing data

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.06.05.137240
N/A
0.104DataRank · unranked
1 citations

Xiangnan Guan, Amy E. Moran, David Z. Qian, Pepper Schedin, Andrew C. Adey +3 more

Androgen receptor activity inversely correlates with immune cell infiltration and immunotherapy response across multiple cancer lineages

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.05.08.593181
N/A
0DataRank · unranked
7 citations

Faming Zhao, Julie N. Graff, Canping Chen, Xiyue Zhao, George Thomas +7 more

Elevated Tumor-Associated Androgen Receptor Activity Correlates with Poor Immune Infiltration and Immunotherapy Response across Cancer Types

Cancer Research Communications(2025)10.1158/2767-9764.crc-25-0409
N/A
0DataRank · unranked
2 citations

Faming Zhao, Julie N. Graff, Canping Chen, Yi Zhang, Jayne M. Stommel +11 more

3D Printing of a Biocompatible Double Network Elastomer with Digital Control of Mechanical Properties

Advanced Functional Materials(2020)10.1002/adfm.201910391
N/A
0DataRank · unranked
49 citations

David B. Berry, Zhaoqiang Song, Wisarut Kiratitanaporn, Jacob Schimelman, Amy E. Moran +5 more

Genomic and molecular associations with preoperative immune checkpoint inhibition in patients with stage III clear cell renal cell carcinoma

medRxiv(2025)10.1101/2025.07.31.25332518
N/A
0DataRank · unranked
0 citations

Lucy Lawrence, Emma Neham, Shreeram Akilesh, Amy E. Moran, Christopher L. Corless +10 more

PD-1 Specific ‘Blocking’ Antibodies That Deplete PD-1+ T Cells Present An Inconvenient Variable In Pre-clinical Immunotherapy Experiments

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.04.14.041608
N/A
0DataRank · unranked
1 citations

Michael W. Munks, Katherine H. Rott, Savannah M. Smart, Ann B. Hill, Amy E. Moran +1 more

Phenotype-guided subpopulation identification from single-cell sequencing data

Research Square(2021)10.21203/rs.3.rs-493014/v1
N/A
0DataRank · unranked
2 citations

Xiangnan Guan, Amy E. Moran, David Z. Qian, Pepper Schedin, Mu‐Shui Dai +6 more

Androgen receptor activity in T cells limits checkpoint blockade efficacy

Nature(2022)10.1038/s41586-022-04522-6
N/A
0DataRank · unranked
398 citations

Fanny Polesso, Chaojie Wang, Archana Sehrawat, Reed M. Hawkins, Susan Murray +10 more

Identification of Cellular Interactions in the Tumor Immune Microenvironment Underlying CD8 T Cell Exhaustion

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.11.09.566384
N/A
0DataRank · unranked
2 citations

Amy E. Moran, Andrew C. Adey, Shannon K. McWeeney, Guanming Wu, Christopher Klocke

PD-1 Limits IL-2 Production and Thymic Regulatory T Cell Development

ImmunoHorizons(2024)10.4049/immunohorizons.2300079
N/A
0DataRank · unranked
1 citations

Benjamin R. Weeder, Reid F. Thompson, Amy E. Moran, Breanna Caruso